Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_2

25%

Ph phase_3

50%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

Phase 3Large-scale testing

2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(2)

Detailed Status

Completed2

Withdrawn1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 21 (25.0%)

Phase 32 (50.0%)

Trials by Status

withdrawn125%

completed250%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_3

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00044291

withdrawnphase_2

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

NCT00080613

completedphase_1

Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men

NCT00740194

terminatedphase_3

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00097344

Clinical Trials (4)

Showing 4 of 4 trials

NCT00044291Phase 3

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Completed

NCT00080613Phase 2

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Withdrawn

NCT00740194Phase 1

Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men

Completed

NCT00097344Phase 3

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4